Table 2.
PEI | Year 2000–02 | Year 2003–05 | Year 2006–08 | |||
---|---|---|---|---|---|---|
% (95%CI) | OR (95%CI) | % (95%CI) | OR (95%CI) | % (95%CI) | OR (95%CI) | |
Lifetime smoking | ||||||
0 | 44.1(41.8, 46.4) | 1.00 (n/a) | 40.8(38.5, 43.0) | 1.00 (n/a) | 35.0(33.0, 36.9) | 1.00 (n/a) |
1 | 40.1(38.8, 41.5) | 0.85(0.76, 0.95) | 35.8(34.5, 37.0) | 0.81(0.73, 0.90) | 30.6(29.5, 31.8) | 0.82(0.74, 0.91) |
2 | 37.1(36.1, 38.2) | 0.75(0.67, 0.83) | 33.5(32.6, 34.5) | 0.73(0.66, 0.81) | 26.6(25.7, 27.5) | 0.67(0.61, 0.74) |
3 | 34.8(33.9, 35.7) | 0.67(0.61, 0.75) | 29.7(28.8, 30.5) | 0.61(0.55, 0.68) | 23.4(22.6, 24.2) | 0.57(0.52, 0.62) |
4 | 31.6(30.7, 32.5) | 0.58(0.53, 0.65) | 27.1(26.3, 27.9) | 0.54(0.49, 0.60) | 22.6(21.8, 23.4) | 0.54(0.49, 0.60) |
5+ | 29.8(28.8, 30.7) | 0.54(0.48, 0.59) | 25.2(24.4, 26.1) | 0.49(0.44, 0.54) | 21.5(20.7, 22.4) | 0.51(0.46, 0.56) |
Current smoking | ||||||
0 | 21.3(19.5, 23.2) | 1.00 (n/a) | 21.6(19.7, 23.5) | 1.00 (n/a) | 16.5(15.0, 18.0) | 1.00 (n/a) |
1 | 16.8(15.8, 17.8) | 0.74(0.65, 0.85) | 14.6(13.7, 15.5) | 0.62(0.54, 0.71) | 13.4(12.5, 14.2) | 0.78(0.68, 0.89) |
2 | 14.7(14.0, 15.5) | 0.64(0.56, 0.72) | 13.4(12.7, 14.1) | 0.56(0.49, 0.64) | 10.2( 9.6, 10.8) | 0.57(0.50, 0.65) |
3 | 13.2(12.5, 13.8) | 0.56(0.49, 0.63) | 11.6(11.0, 12.2) | 0.48(0.42, 0.54) | 9.1( 8.6, 9.7) | 0.51(0.45, 0.57) |
4 | 11.4(10.8, 12.0) | 0.47(0.42, 0.54) | 10.2( 9.7, 10.7) | 0.41(0.36, 0.47) | 9.0( 8.5, 9.5) | 0.50(0.44, 0.57) |
5+ | 11.0(10.3, 11.7) | 0.45(0.40, 0.52) | 10.0(9.4, 10.6) | 0.40(0.35, 0.46) | 8.5( 7.9, 9.0) | 0.47(0.41, 0.53) |
Note: PEI: Program exposure index; OR: Odds ratio, computed using data for participants with PEI = 0 as the reference group (OR = 1.00). Cochran-Armtage Trend test indicated a significant dose-response relation between PEI and the prevalence of lifetime smoking and current smoking at all three periods (p<0.0101) for all.